CSIMarket
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Operating Income Growth by Quarter and Year

Atara Biotherapeutics,'s Operating Income results by quarter and year




ATRA Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -81.82 -35.80 -18.75
III Quarter September - -60.22 -31.66 -25.94
II Quarter June -75.54 -52.62 -27.91 -19.49
I Quarter March -67.89 -42.45 -26.16 -17.06
FY   -143.43 -237.11 -121.53 -81.24



ATRA Operating Income second quarter 2019 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the second quarter recorded Operating Loss of $ -75.54 millions.

According to the results reported in the second quarter, Atara Biotherapeutics, Inc. achieved the best Operating Income growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s Operating Income no change of % ranks overall at the positon no. in the second quarter.

Explain Operating Income growth


ATRA Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s second quarter 2019 Operating Income $ -75.54 millions ATRA's Income Statement
Atara Biotherapeutics,'s second quarter 2018 Operating Income $ -52.62 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Operating Income Growth >>


ATRA Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Atara Biotherapeutics,'s Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Operating Income Comment
II. Quarter 2019 Operating Loss of -75.54 millions by Atara Biotherapeutics, Inc. look even more unfavourable compare to the -67.89 millions Operating Loss a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Operating Income growth. While Atara Biotherapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -75.54 millions by Atara Biotherapeutics, Inc. appear even less good considering the -67.89 millions in the first quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Operating Income growth. While Atara Biotherapeutics,'s Operating Income growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ -285.46 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -285 millions in the Jun 30 2019 period.
The results are getting worse as the cumulative Operating Loss is getting bigger from $ -262.55 millions for the period from to and $ -67.89 millions for the twelve months ending in the quarter .

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months Operating Loss of $ -285 millions in the Jun 30 2019 period.
The situation is worsening as the cumulative Operating Loss is getting bigger from $ -262.55 millions in the twelve months ending a quarter before and $ -67.89 millions for the twelve months ending in the quarter Vanessa D. Reed mentioned.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ATRA's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ATRA's Competitors
Operating Income Growth for Atara Biotherapeutics,'s Suppliers
Operating Income Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jun 30 2019
Insulet Corporation  75.79 %$ 75.792 millions
Semler Scientific, Inc.  75.57 %$ 75.570 millions
Merck & Co., Inc.  66.78 %$ 66.781 millions
Integra Lifesciences Holdings Corp  66.31 %$ 66.313 millions
Biogen Inc.  61.22 %$ 61.218 millions
Vertex Pharmaceuticals Inc  56.16 %$ 56.156 millions
Staar Surgical Co  52.38 %$ 52.379 millions
Medpace Holdings, Inc.  51.03 %$ 51.034 millions
Tivity Health, Inc.  47.52 %$ 47.523 millions
Align Technology Inc  43.85 %$ 43.849 millions
Biospecifics Technologies Corp  42.13 %$ 42.130 millions
Celgene Corp  42.06 %$ 42.059 millions
Iradimed Corp  41.80 %$ 41.796 millions
Biotelemetry, Inc.  41.27 %$ 41.266 millions
Radnet, Inc.  38.53 %$ 38.526 millions
Penumbra Inc  37.90 %$ 37.897 millions
Abbott Laboratories  36.73 %$ 36.735 millions
Lhc Group, Inc  36.59 %$ 36.586 millions
West Pharmaceutical Services, Inc.  33.50 %$ 33.499 millions
Jazz Pharmaceuticals Plc  33.34 %$ 33.345 millions
Lifevantage Corp  31.81 %$ 31.814 millions
National Research Corporation  30.85 %$ 30.854 millions
Abiomed Inc  29.90 %$ 29.899 millions
Icon Plc  29.52 %$ 29.517 millions
Intuitive Surgical Inc  29.42 %$ 29.416 millions
Bio-rad Laboratories, Inc.  28.77 %$ 28.768 millions
Ani Pharmaceuticals Inc  27.94 %$ 27.936 millions
Surgery Partners, Inc.  27.41 %$ 27.408 millions
Abbvie Inc.  23.10 %$ 23.099 millions
Becton, Dickinson And Company  22.03 %$ 22.027 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OMN's Profile

Stock Price

OMN's Financials

Business Description

Fundamentals

Charts & Quotes

OMN's News

Suppliers

OMN's Competitors

Customers & Markets

Economic Indicators

OMN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071